Get the latest news, insights, and market updates on CYCN (Cyclerion Therapeutics, Inc.). Explore the news page 1 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
CYCN: Positive Feedback from FDA Sets Stage for Phase 2 Trial of CYC-126 in 2H26
By David Bautz, PhD NASDAQ:CYCN READ THE FULL CYCN RESEARCH REPORT Business Update Positive Regulatory Feedback Supports Phase 2 Trial Initiation in 2H26 On February 17, 2026, Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) announced that the U.S. Food and Drug Administration (FDA) provided positive written feedback to the company regarding the planned Phase 2 proof-of-concept clinical trial Feb 23, 2026 - $CYCN
Cyclerion Therapeutics Announces Progress Toward CYC-126 Phase 2 Proof-of-Concept Study with FDA Feedback and Formation of Clinical Advisory Board
–Received Positive Pre-Investigational New Drug (“IND”) Written Feedback from the U.S. Food and Drug Administration (“FDA”)– –Clinical Advisory Board (“CAB”) Includes Key Leaders across Neuropsychiatry, Anesthesiology, and Clinical Development– –Remain On Track to Initiate CYC-126's Phase 2 Proof-of-Concept (“POC”) Study in Treatment Resistant Depression (“TRD”) in the Second Half of 2026– CAMBRIDGE, Mass., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) (“Cyclerion Feb 17, 2026 - $CYCN
CYCN: Engineering a Reset; Initiating Coverage of Cyclerion Therapeutics…
By David Bautz, PhD NASDAQ:CYCN READ THE FULL CYCN RESEARCH REPORT Initiating Coverage We are initiating coverage of Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) with a valuation of $8.00. Cyclerion is a clinical-stage biopharmaceutical company that has recently undergone a strategic transformation to focus on the development of novel neuropsychiatric therapies, with an initial emphasis on Feb 2, 2026 - $CYCN
EXCLUSIVE: Cycurion Wins $1 Million+ Contract To Modernize Federal Emergency Warning Network
Cybersecurity and IT services company Cycurion, Inc. (NASDAQ:CYCU) announced Monday that it has bagged a contract with a leading telecommunications company to deliver network deployment services supporting a critical modernization initiative for one of the federal government's largest agencies. The rollout encompasses more than 1,300 sites across all 50 states and U.S. territories, with an expected duration of 24 to 36 months and a potential total value exceeding $1 million. The multi-year proje Nov 10, 2025 - $CYCN
Cyclerion Announces Transformational Relaunch as a Neuropsychiatric Company
– Cyclerion Relaunches, Advancing a Phase 2–Ready Program for Millions Living with Treatment-Resistant Depression Through MIT License Agreement – – Webcast to be held September 24, 2025 at 10:30 a.m. ET – CAMBRIDGE, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. today announced that it has entered into a licensing agreement with the Massachusetts Institute of Technology (“MIT”), securing the intellectual property that will serve as the cornerstone of its strategic relaunc Sep 23, 2025 - $CYCN
3 US Penny Stocks With Market Caps Over $10M To Consider
As investors navigate a mixed market landscape, with major indices showing varied performances amid a wave of earnings reports, the allure of smaller investment opportunities remains significant. Penny stocks, though often associated with speculative trading, still hold potential when backed by robust financials. These companies can offer unique growth prospects and value that larger firms may overlook. In this article, we explore several penny stocks that stand out for their financial... Feb 5, 2025 - $CYCN
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple